These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 28007725)

  • 41. Computerized documentation of pharmacists' interventions.
    Mason RN; Pugh CB; Boyer SB; Stiening KK
    Am J Hosp Pharm; 1994 Sep; 51(17):2131-8. PubMed ID: 7985688
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 1993 Bibliography: a 32-year literature review on the value and acceptance of ambulatory care provided by pharmacists.
    Hatoum HT; Akhras K
    Ann Pharmacother; 1993 Sep; 27(9):1106-19. PubMed ID: 8219447
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Academic pharmacy and patient-centered health care: a model to prepare the next generation of pharmacists.
    Haines SL; DeHart RM; Flynn AA; Hess KM; Marciniak MW; Mount J; Phillips BB; Saseen JJ; Zatzkin SW
    J Am Pharm Assoc (2003); 2011; 51(2):194-202. PubMed ID: 21382810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Specialty pharmacies and other restricted drug distribution systems: financial and safety considerations for patients and health-system pharmacists.
    Kirschenbaum BE
    Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S13-20. PubMed ID: 19966075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implementation of additional prescribing authorization among oncology pharmacists in Alberta.
    Au B; Dersch-Mills D; Ghosh S; Jupp J; Chambers C; Cusano F; Danilak M
    J Oncol Pharm Pract; 2019 Apr; 25(3):584-598. PubMed ID: 29338572
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic drug monitoring in ambulatory care.
    Goode MA; Gums JG
    Ann Pharmacother; 1993 Apr; 27(4):502-5. PubMed ID: 8477129
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A primer for developing pharmacist-managed clinics in the outpatient setting.
    Snella KA; Sachdev GP
    Pharmacotherapy; 2003 Sep; 23(9):1153-66. PubMed ID: 14524647
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness of an ambulatory care clinical pharmacist: a controlled trial.
    Mason JD; Colley CA
    Ann Pharmacother; 1993 May; 27(5):555-9. PubMed ID: 8347901
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sustainable business models: systematic approach toward successful ambulatory care pharmacy practice.
    Sachdev G
    Am J Health Syst Pharm; 2014 Aug; 71(16):1366-74. PubMed ID: 25074956
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ASHP survey of ambulatory care pharmacy practice in health systems--2004.
    Knapp KK; Okamoto MP; Black BL
    Am J Health Syst Pharm; 2005 Feb; 62(3):274-84. PubMed ID: 15719585
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and cost-saving interventions performed by pharmacists in a community health clinic pharmacy.
    Kubitz-Klingel C; Reeg-Dhingra M; Oehlert A; Liddell E
    J Am Pharm Assoc (2003); 2007; 47(2):188-90. PubMed ID: 17510007
    [No Abstract]   [Full Text] [Related]  

  • 52. Renal nurses' views of the potential role of pharmacists in outpatient dialysis centres: a qualitative study.
    Salgado TM; Moles R; Benrimoj SI; Fernandez-Llimos F
    Int J Pharm Pract; 2014 Aug; 22(4):300-3. PubMed ID: 24754627
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Implementation, justification, and expansion of ambulatory clinical pharmacy services.
    Lepinski PW; Woller TW; Abramowitz PW
    Top Hosp Pharm Manage; 1992 Jan; 11(4):86-92. PubMed ID: 10128691
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expansion of clinical pharmacy through increased use of outpatient pharmacists for anticoagulation services.
    Philip A; Green M; Hoffman T; Gautreaux S; Wallace D; Roux R; Garey KW
    Am J Health Syst Pharm; 2015 Apr; 72(7):568-72. PubMed ID: 25788511
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacist value-added to neuro-oncology subspecialty clinics: A pilot study uncovers opportunities for best practices and optimal time utilization.
    Lee GW; Mathur AD; Andrick BJ; Leese E; Zally D; Gatson NTN
    J Oncol Pharm Pract; 2020 Dec; 26(8):1937-1941. PubMed ID: 32938297
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of pharmacist interventions on cost avoidance in an ambulatory cancer center.
    Randolph LA; Walker CK; Nguyen AT; Zachariah SR
    J Oncol Pharm Pract; 2018 Jan; 24(1):3-8. PubMed ID: 27682600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validation of a survey tool assessing effectiveness of an educational intervention on the caring behaviors and referral activities of community pharmacists for migraineurs.
    O'Neal KS; Murray KA; Skomo ML; Carter SM; McConaha J
    Res Social Adm Pharm; 2015; 11(3):352-63. PubMed ID: 25483402
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The IMPROVE study: background and study design. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers.
    Carter BL; Malone DC; Valuck RJ; Barnette DJ; Sintek CD; Billups SJ
    Am J Health Syst Pharm; 1998 Jan; 55(1):62-7. PubMed ID: 9437477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ambulatory surgery centers: short-term stays mean long-term opportunities for pharmacists.
    Kaldy J
    Consult Pharm; 2012 Dec; 27(12):838-43. PubMed ID: 23229071
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Implementation and outcomes of a pharmacist-managed clinical video telehealth anticoagulation clinic.
    Singh LG; Accursi M; Korch Black K
    Am J Health Syst Pharm; 2015 Jan; 72(1):70-3. PubMed ID: 25511842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.